acetovanillone has been researched along with Carcinogenesis in 6 studies
apocynin : An aromatic ketone that is 1-phenylethanone substituted by a hydroxy group at position 4 and a methoxy group at position 3.
Carcinogenesis: The origin, production or development of cancer through genotypic and phenotypic changes which upset the normal balance between cell proliferation and cell death. Carcinogenesis generally requires a constellation of steps, which may occur quickly or over a period of many years.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The present study aimed to evaluate the chemopreventive effects of resveratrol (RV) and apocynin (AC) in N-Nitrosobis(2-oxopropyl)amine-induced pancreatic carcinogenesis in hamster." | 7.81 | Chemopreventive effect of resveratrol and apocynin on pancreatic carcinogenesis via modulation of nuclear phosphorylated GSK3β and ERK1/2. ( Hayashi, K; Hori, Y; Joh, T; Kato, A; Kato, H; Kondo, H; Kuno, T; Miyabe, K; Mori, T; Naiki-Ito, A; Naitoh, I; Nakazawa, T; Nishi, Y; Ohara, H; Shimizu, S; Suzuki, S; Takahashi, S; Tsutsumi, M; Umemura, S; Yoshida, M, 2015) |
| "We determined effects of the NADPH oxidase (NOX) inhibitor apocynin (APO) or the antioxidant enzymatically modified isoquercitrin (EMIQ) on an early stage of hepatocarcinogenesis in the liver with steatosis." | 3.85 | Apocynin and enzymatically modified isoquercitrin suppress the expression of a NADPH oxidase subunit p22phox in steatosis-related preneoplastic liver foci of rats. ( Abe, H; Hayashi, SM; Kangawa, Y; Kawashima, M; Kimura, M; Mizukami, S; Murayama, H; Nagahara, R; Shibutani, M; Yoshida, T, 2017) |
| " The present study aimed to evaluate the chemopreventive effects of resveratrol (RV) and apocynin (AC) in N-Nitrosobis(2-oxopropyl)amine-induced pancreatic carcinogenesis in hamster." | 3.81 | Chemopreventive effect of resveratrol and apocynin on pancreatic carcinogenesis via modulation of nuclear phosphorylated GSK3β and ERK1/2. ( Hayashi, K; Hori, Y; Joh, T; Kato, A; Kato, H; Kondo, H; Kuno, T; Miyabe, K; Mori, T; Naiki-Ito, A; Naitoh, I; Nakazawa, T; Nishi, Y; Ohara, H; Shimizu, S; Suzuki, S; Takahashi, S; Tsutsumi, M; Umemura, S; Yoshida, M, 2015) |
| " pylori-induced pit abscess formation without indications of drug toxicity and thus further investigation of the dosage regimen and formulation and the long-term impact on neoplastic development should be carried out." | 1.46 | In-vivo evaluation of apocynin for prevention of Helicobacter pylori-induced gastric carcinogenesis. ( Bogers, J; Boulet, G; Cos, P; Delputte, P; Horemans, T; Maes, L; Thys, S; van Kerckhoven, M; Vervaeck, A; Vervaet, C, 2017) |
| "Obesity is a risk factor for colorectal cancer." | 1.42 | Suppressive effects of the NADPH oxidase inhibitor apocynin on intestinal tumorigenesis in obese KK-A(y) and Apc mutant Min mice. ( Fujii, G; Fujimoto, K; Ishigamori, R; Ishino, K; Komiya, M; Miyamoto, S; Mutoh, M; Onuma, W; Takahashi, M; Totsuka, Y, 2015) |
| "In human prostate cancer cell line LNCaP, apocynin also inhibited reactive oxygen species production and blocked cell growth by inducing G0/G1 arrest with downregulation of clusterin and cyclin D1." | 1.39 | Apocynin, an NADPH oxidase inhibitor, suppresses rat prostate carcinogenesis. ( Naiki-Ito, A; Punfa, W; Sato, S; Shiraga, K; Shirai, T; Suzuki, S; Takahashi, S; Yamashita, Y, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fuji, S | 1 |
| Suzuki, S | 3 |
| Naiki-Ito, A | 3 |
| Kato, H | 2 |
| Hayakawa, M | 1 |
| Yamashita, Y | 2 |
| Kuno, T | 2 |
| Takahashi, S | 3 |
| Shiraga, K | 1 |
| Sato, S | 1 |
| Punfa, W | 1 |
| Shirai, T | 1 |
| Komiya, M | 1 |
| Fujii, G | 1 |
| Miyamoto, S | 1 |
| Takahashi, M | 1 |
| Ishigamori, R | 1 |
| Onuma, W | 1 |
| Ishino, K | 1 |
| Totsuka, Y | 1 |
| Fujimoto, K | 1 |
| Mutoh, M | 1 |
| Kato, A | 1 |
| Nakazawa, T | 1 |
| Hayashi, K | 1 |
| Naitoh, I | 1 |
| Miyabe, K | 1 |
| Shimizu, S | 1 |
| Kondo, H | 1 |
| Nishi, Y | 1 |
| Yoshida, M | 1 |
| Umemura, S | 1 |
| Hori, Y | 1 |
| Mori, T | 1 |
| Tsutsumi, M | 1 |
| Ohara, H | 1 |
| Joh, T | 1 |
| Horemans, T | 1 |
| Boulet, G | 1 |
| van Kerckhoven, M | 1 |
| Bogers, J | 1 |
| Thys, S | 1 |
| Vervaet, C | 1 |
| Vervaeck, A | 1 |
| Delputte, P | 1 |
| Maes, L | 1 |
| Cos, P | 1 |
| Yoshida, T | 1 |
| Murayama, H | 1 |
| Kawashima, M | 1 |
| Nagahara, R | 1 |
| Kangawa, Y | 1 |
| Mizukami, S | 1 |
| Kimura, M | 1 |
| Abe, H | 1 |
| Hayashi, SM | 1 |
| Shibutani, M | 1 |
6 other studies available for acetovanillone and Carcinogenesis
| Article | Year |
|---|---|
The NADPH Oxidase Inhibitor Apocynin Suppresses Preneoplastic Liver Foci of Rats.
Topics: Acetophenones; Animals; Anticarcinogenic Agents; Body Weight; Carcinogenesis; Cell Proliferation; Cy | 2017 |
Apocynin, an NADPH oxidase inhibitor, suppresses rat prostate carcinogenesis.
Topics: Acetophenones; Adenocarcinoma; Animals; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Cluste | 2013 |
Suppressive effects of the NADPH oxidase inhibitor apocynin on intestinal tumorigenesis in obese KK-A(y) and Apc mutant Min mice.
Topics: Acetophenones; Animals; Antineoplastic Agents; Carcinogenesis; Cell Line, Tumor; Chromatography, Liq | 2015 |
Chemopreventive effect of resveratrol and apocynin on pancreatic carcinogenesis via modulation of nuclear phosphorylated GSK3β and ERK1/2.
Topics: Acetophenones; Adenocarcinoma; Animals; Anticarcinogenic Agents; Antioxidants; Blotting, Western; Ca | 2015 |
In-vivo evaluation of apocynin for prevention of Helicobacter pylori-induced gastric carcinogenesis.
Topics: Acetophenones; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carcinogenesis; Cell Line; Cell Sur | 2017 |
Apocynin and enzymatically modified isoquercitrin suppress the expression of a NADPH oxidase subunit p22phox in steatosis-related preneoplastic liver foci of rats.
Topics: Acetophenones; Animals; Carcinogenesis; Disease Models, Animal; Enzyme Inhibitors; Fatty Liver; Immu | 2017 |